Reto terapéutico, los nuevos anticoagulantes orales en la práctica médica

Abstract

Venezuelans Medicine faces difficult times because of the current crisis, however, it is not an excuse to be at the forefront of knowledge, and the topic of anticoagulation is one of the most important in recent times. At present we have new agents called new anticoagulants oral NACO, this generates a paradigm since some colleagues continue with the traditional anticoagulation schemes and others opt for these new agents, a conflict between the traditional and these new molecules for the facultative what daily treat millions of patients who receive these medications daily either as a treatment or to prevent the recurrence of thromboembolic events. It is then that it has been considered if the end of therapeutics with heparins or coumarins has come, this has generated a great controversy and there are many questions about this topic that have not been answered in the studies, it is for that reason that the extensive experience that has had with the traditional agents by multiple decades makes the doctors are cautious and do not dare to change the therapy, although everything points to that destination.